The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Sunday, April 27, 2014
FDA okays start of BrainStorm stem cell trial in ALS patients
BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis .
No comments:
Post a Comment